MIPS Project Challenge:
Sterilex originally developed a proprietary technology to remove biofilm and kill resistant biofilm microorganisms on devices, equipment and hard surfaces. The company wanted to develop protocols and efficacy data for an application of this technology to remove biofilms and kill biofilm microorganisms in dental unit waterlines, enabling dentists to provide safe water during dental procedures. Data was also needed to obtain regulatory approvals for biofilm claims, and for use of the products in dental equipment.

Project Scope:
MIPS funding enabled a research professor at the University of Maryland Dental School in Baltimore to work with the company to optimize the anti-biofilm disinfectant and to develop protocols for its use in dental offices. Sterilex’s patented anti-biofilm disinfectants have been customized to address sanitation challenges, solving quality control problems for which routine disinfectants and sanitizers are ineffective. Sterilex’s disinfectants are broad spectrum, effective against a variety of microorganisms and because they act through multiple physical and chemical (nonreceptor-based) modes of action, they do not induce antimicrobial resistance.